
Feng Zhang, a researcher at MIT and the Broad Institute and one of the pioneers of genetic editing with CRISPR, described the finding as "really intriguing" and considered it worthy of deeper investigation.
What role artificial intelligence played in the discovery
Dario Amodei, CEO of Anthropic, stated that Claude did most of the work, although not all of it. The model reviewed scientific studies, analyzed genomic data, identified possible patterns, and proposed experiments that were then carried out by the researchers.
Amodei asserted that artificial intelligence could accelerate biological research, although he emphasized that discoveries must be validated in the laboratory. He also suggested that, in the future, Claude could autonomously control research teams, something that does not currently happen.

Anthropic indicated that its facilities operate with biosecurity levels BSL-1 and BSL-2. The discovery of ART is a first step towards the possibility of using artificial intelligence to find new biological systems, but it still requires more testing.










